E1A-Associated p300 Protein
"E1A-Associated p300 Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the p300-CBP transcription factors that was originally identified as a binding partner for ADENOVIRUS E1A PROTEINS.
| Descriptor ID |
D050881
|
| MeSH Number(s) |
D08.811.913.050.134.415.500.575.600 D12.776.930.680.600
|
| Concept/Terms |
E1A-Associated p300 Protein- E1A-Associated p300 Protein
- E1A Associated p300 Protein
- p300 Protein, E1A-Associated
- p300 E1A-Associated Coactivator
- E1A-Associated Coactivator, p300
- p300 E1A Associated Coactivator
|
Below are MeSH descriptors whose meaning is more general than "E1A-Associated p300 Protein".
Below are MeSH descriptors whose meaning is more specific than "E1A-Associated p300 Protein".
This graph shows the total number of publications written about "E1A-Associated p300 Protein" by people in this website by year, and whether "E1A-Associated p300 Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "E1A-Associated p300 Protein" by people in Profiles.
-
Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53. Theranostics. 2019; 9(21):6047-6062.
-
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency. Pediatr Allergy Immunol. 2018 11; 29(7):776-781.
-
Rubinstein-Taybi syndrome: New neuroradiological and neuropsychiatric insights from a multidisciplinary approach. Am J Med Genet B Neuropsychiatr Genet. 2018 06; 177(4):406-415.
-
Chemical and genetic rescue of an ep300 knockdown model for Rubinstein Taybi Syndrome in zebrafish. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 1864(4 Pt A):1203-1215.
-
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort. J Hematol Oncol. 2017 03 17; 10(1):70.
-
Methylene blue increases the amount of HSF1 through promotion of PKA-mediated increase in HSF1-p300 interaction. Int J Biochem Cell Biol. 2017 03; 84:75-88.